Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Plasma alpha-synuclein is decreased in subjects with Parkinson's disease.

Li QX, Mok SS, Laughton KM, McLean CA, Cappai R, Masters CL, Culvenor JG, Horne MK.

Exp Neurol. 2007 Apr;204(2):583-8. Epub 2006 Dec 19.

PMID:
17258710
2.

Platelet alpha- and gamma-synucleins in Parkinson's disease and normal control subjects.

Li QX, Campbell BC, McLean CA, Thyagarajan D, Gai WP, Kapsa RM, Beyreuther K, Masters CL, Culvenor JG.

J Alzheimers Dis. 2002 Aug;4(4):309-15.

PMID:
12446933
3.

Plasma alpha-synuclein in patients with Parkinson's disease with and without treatment.

Duran R, Barrero FJ, Morales B, Luna JD, Ramirez M, Vives F.

Mov Disord. 2010 Mar 15;25(4):489-93. doi: 10.1002/mds.22928.

PMID:
20063406
4.

The native form of alpha-synuclein is not found in the cerebrospinal fluid of patients with Parkinson's disease or normal controls.

Jakowec MW, Petzinger GM, Sastry S, Donaldson DM, McCormack A, Langston JW.

Neurosci Lett. 1998 Aug 28;253(1):13-6.

PMID:
9754793
5.

Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects.

Bloch A, Probst A, Bissig H, Adams H, Tolnay M.

Neuropathol Appl Neurobiol. 2006 Jun;32(3):284-95.

PMID:
16640647
6.

Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.

Foulds PG, Mitchell JD, Parker A, Turner R, Green G, Diggle P, Hasegawa M, Taylor M, Mann D, Allsop D.

FASEB J. 2011 Dec;25(12):4127-37. doi: 10.1096/fj.10-179192. Epub 2011 Aug 24.

PMID:
21865317
7.

Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.

El-Agnaf OM, Salem SA, Paleologou KE, Curran MD, Gibson MJ, Court JA, Schlossmacher MG, Allsop D.

FASEB J. 2006 Mar;20(3):419-25.

PMID:
16507759
8.

Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.

Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, Takahashi H.

Brain. 2008 Mar;131(Pt 3):642-50. Epub 2007 Dec 13.

PMID:
18079166
9.

Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.

Chiba-Falek O, Lopez GJ, Nussbaum RL.

Mov Disord. 2006 Oct;21(10):1703-8.

PMID:
16795004
10.

The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.

Wakabayashi K, Tanji K, Mori F, Takahashi H.

Neuropathology. 2007 Oct;27(5):494-506. Review.

PMID:
18018486
11.

alpha-synuclein from platelets is not phosphorylated at serine 129 in Parkinson's disease and multiple system atrophy.

Shults CW, Barrett JM, Fontaine D.

Neurosci Lett. 2006 Sep 25;405(3):223-5. Epub 2006 Aug 9.

PMID:
16901642
12.

Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease.

Tokuda T, Salem SA, Allsop D, Mizuno T, Nakagawa M, Qureshi MM, Locascio JJ, Schlossmacher MG, El-Agnaf OM.

Biochem Biophys Res Commun. 2006 Oct 13;349(1):162-6. Epub 2006 Aug 14.

PMID:
16930553
13.

[Lewy body formation in Parkinson's disease: neurodegeneration or neuroprotection?].

Wakabayashi K.

Rinsho Shinkeigaku. 2008 Nov;48(11):981-3. Review. Japanese.

PMID:
19198138
14.

Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?

Ohrfelt A, Grognet P, Andreasen N, Wallin A, Vanmechelen E, Blennow K, Zetterberg H.

Neurosci Lett. 2009 Feb 6;450(3):332-5. doi: 10.1016/j.neulet.2008.11.015. Epub 2008 Nov 12.

PMID:
19022350
15.

[Frequency of the IVS4+66A-G polymorphism in the alpha-synuclein gene in patients with Parkinson's disease in north-western Mexico].

Ramírez-Jirano LJ, Ruiz-Sandoval JL, Jiménez-Gil FJ, Ramírez-Vega J, Vargas-Frutos E, Gallegos-Arreola MP.

Rev Neurol. 2007 Jan 1-15;44(1):15-7. Spanish.

16.

Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material.

Westerlund M, Belin AC, Anvret A, Håkansson A, Nissbrandt H, Lind C, Sydow O, Olson L, Galter D.

FASEB J. 2008 Oct;22(10):3509-14. doi: 10.1096/fj.08-110148. Epub 2008 Jul 7.

PMID:
18606870
17.
18.

Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.

El-Agnaf OM, Salem SA, Paleologou KE, Cooper LJ, Fullwood NJ, Gibson MJ, Curran MD, Court JA, Mann DM, Ikeda S, Cookson MR, Hardy J, Allsop D.

FASEB J. 2003 Oct;17(13):1945-7. Epub 2003 Aug 15.

PMID:
14519670
19.

Decreased activities of lysosomal acid alpha-D-galactosidase A in the leukocytes of sporadic Parkinson's disease.

Wu G, Yan B, Wang X, Feng X, Zhang A, Xu X, Dong H.

J Neurol Sci. 2008 Aug 15;271(1-2):168-73. doi: 10.1016/j.jns.2008.04.011. Epub 2008 May 20.

PMID:
18495164
20.

Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.

Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK.

J Biol Chem. 2008 Apr 4;283(14):9089-100. doi: 10.1074/jbc.M710012200. Epub 2008 Feb 1.

Supplemental Content

Support Center